Everolimus: all 667 studies that test it
Page 6 of 7. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- Lapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerStatus unknownNCT01283789Phase 2
- A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerCompletedNCT01281514Phase 1
- Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal TransplantationTerminatedNCT01276834Phase 4
- Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant RecipientsWithdrawnNCT01269684Phase 4
- Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)CompletedNCT01266837Phase 4
- Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib AloneStatus unknownNCT01263951Phase 2
- A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior ChemotherapyCompletedNCT01248403Phase 3
- Everolimus for Patients With Relapsed/Refractory Germ Cell CancerCompletedNCT01242631Phase 2
- IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor EverolimusWithdrawnNCT01234974Phase 2
- Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular TargetsSuspendedNCT01226056Phase 1/2
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2
- A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix CancerCompletedNCT01217177Phase 1
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue SarcomasStatus unknownNCT01216839Phase 2
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed OsteosarcomaStatus unknownNCT01216826Phase 2
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
- RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell LymphomasCompletedNCT01198665Phase 1/2
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
- RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.WithdrawnNCT01188889Phase 1/2
- An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive RegimensCompletedNCT01183247Phase 4
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor MalignanciesCompletedNCT01182168Phase 1
- Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers SyndromeWithdrawnNCT01178151Phase 2
- Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorStatus unknownNCT01175096Phase 1/2
- Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung CancerCompletedNCT01167530Phase 1
- Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)CompletedNCT01164267Phase 2
- Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerCompletedNCT01164176Phase 2
- Everolimus and LongActing Octreotide Trial in Polycystic LiversCompletedNCT01157858Phase 2
- Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01154439Phase 1
- Study of RAD001 in Adenoid Cystic CarcinomaCompletedNCT01152840Phase 2
- RAD001 in Pheochromocytoma or Nonfunctioning CarcinoidCompletedNCT01152827Phase 2
- Safety of RAD001 in Chinese Patients With Metastatic Renal Cell CancerCompletedNCT01152801Phase 1
- Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid CancerActive, not recruitingNCT01141309Phase 2
- Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal CancerCompletedNCT01139138Phase 1/2
- Study of RAD001 + AMG479 for Patients With Advanced Solid TumorsCompletedNCT01122199Phase 1
- Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid CancerStatus unknownNCT01118065Phase 2
- Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of BiomarkersCompletedNCT01107509Not applicable
- A Trial of RAD001/Capecitabine in Refractory Gastric CancerCompletedNCT01099527Phase 1/2
- A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)TerminatedNCT01096199Phase 1
- Everolimus in Breast Cancer Patients After Pre-operative ChemotherapyStatus unknownNCT01088893Phase 2
- Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced CancerActive, not recruitingNCT01087554Phase 1
- Everolimus and Capecitabine in Patients With Advanced MalignancyStatus unknownNCT01079702Phase 1/2
- Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01079481Phase 1
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2
- Phase I Study in RAD 001 Patients With Relapse AMLCompletedNCT01074086Phase 1
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLCTerminatedNCT01063478Phase 1
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007CompletedNCT01061788Phase 1
- RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck CancerTerminatedNCT01058408Phase 1
- Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid TumorsCompletedNCT01055795Phase 1
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant RecipientsCompletedNCT01046045Phase 4
- Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric JunctionCompletedNCT01042782Phase 1
- A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerTerminatedNCT01042028Phase 1/2
- mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal TransplantationCompletedNCT01028092Phase 3
- Everolimus on CKD Progression in ADPKD PatientsTerminatedNCT01009957Phase 2/3
- Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver CancerTerminatedNCT01009801Phase 1/2
- Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver CancerCompletedNCT01005199Phase 2
- A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid TumorsTerminatedNCT00985374Phase 1
- Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
- Everolimus as First-Line Therapy in Treating Patients With Prostate CancerCompletedNCT00976755Phase 2
- Study of RAD001 in Advanced Cholangiocarcinoma: RADiCholStatus unknownNCT00973713Phase 2
- Pharmacokinetics of Everolimus in Subjects With Hepatic InsufficiencyCompletedNCT00968591Phase 1
- Everolimus Dose Finding Study for Stage IV or Recurrent Cervical CancerWithdrawnNCT00967928Phase 1
- Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus TherapyStatus unknownNCT00966836Phase 3
- Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCompletedNCT00962507Phase 1
- A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer SubjectsCompletedNCT00955773Phase 1
- Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate CancerCompletedNCT00943956Phase 1
- Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00942682Phase 1
- RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck CancerCompletedNCT00935961Phase 1
- Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial CarcinomaTerminatedNCT00933374Phase 2
- Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast CancerStatus unknownNCT00930475Phase 1/2
- RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant NeoplasmsCompletedNCT00927966Phase 1
- Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal TransplantationStatus unknownNCT00903188Phase 4
- Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung CancerTerminatedNCT00892801Phase 1
- Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver TransplantationStatus unknownNCT00890253Phase 2
- Everolimus in Treating Patients With Relapsed or Metastatic Endometrial CancerCompletedNCT00870337Phase 2
- Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck CancerCompletedNCT00858663Phase 1
- Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell TransplantationStatus unknownNCT00856505Phase 1/2
- Everolimus in Treating Women With Breast Cancer That Can Be Removed by SurgeryWithdrawnNCT00855114Phase 2
- Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNCT00849550Phase 1
- RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)CompletedNCT00830895Phase 2
- Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
- Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant PatientsStatus unknownNCT00828503Phase 2
- RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSActive, not recruitingNCT00819546Phase 1
- Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant PatientsCompletedNCT00812786Phase 4
- Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid TumorsTerminatedNCT00807755Phase 1
- Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00804336Phase 1
- CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter TrialCompletedNCT00799188Phase 3
- Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)CompletedNCT00792766Phase 1/2
- A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell CarcinomaCompletedNCT00788060Phase 1
- Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001CompletedNCT00775073Phase 2
- A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid TumorsCompletedNCT00756340Phase 1
- RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple MyelomaCompletedNCT00729638Phase 1
- Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line ChemotherapyTerminatedNCT00727207Phase 2
- Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal FailureCompletedNCT00716573Phase 4
- A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of ChemotherapyCompletedNCT00714025Phase 2
- Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial CancersCompletedNCT00703807Phase 1
- Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart TransplantStatus unknownNCT00695344Phase 4
- Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00680758Phase 1
- Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00674414Phase 2
- Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaTerminatedNCT00671112Phase 1
- Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate CancerStatus unknownNCT00657982Phase 2